← Open Payments lookup

KYLIE JIMENEZ: Open Payments

NPI 1720724701 · ROCKAWAY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$748 in 42 payments from 10 companies in 2025. Trend: 2023 $771 · 2024 $546 · 2025 $748

Food & beverage: $748
CompanyPaymentsAmount
Madrigal Pharmaceuticals9$181
ABBVIE INC.10$166
Ardelyx, Inc.5$86
Aimmune Therapeutics, Inc.4$81
Takeda Pharmaceuticals U.S.A., Inc.4$79
Daiichi Sankyo Inc.3$47
PFIZER INC.3$46
Phathom Pharmaceuticals, Inc.2$29
Ipsen Biopharmaceuticals, Inc1$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$15

Products named: REZDIFFRA, IBSRELA, ZENPEP, LINZESS, ENTYVIO, RINVOQ, INJECTAFER, VELSIPITY.

Industry payments across NJ — which companies pay providers there.